SK12297A3 - Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product - Google Patents

Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product Download PDF

Info

Publication number
SK12297A3
SK12297A3 SK122-97A SK12297A SK12297A3 SK 12297 A3 SK12297 A3 SK 12297A3 SK 12297 A SK12297 A SK 12297A SK 12297 A3 SK12297 A3 SK 12297A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutically acceptable
formula
compound
acceptable salt
benzoxazolyl
Prior art date
Application number
SK122-97A
Other languages
English (en)
Slovak (sk)
Inventor
David Haigh
Harshad K Rami
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415330A external-priority patent/GB9415330D0/en
Priority claimed from GBGB9425599.9A external-priority patent/GB9425599D0/en
Priority claimed from GBGB9509923.0A external-priority patent/GB9509923D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK12297A3 publication Critical patent/SK12297A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK122-97A 1994-07-29 1995-07-28 Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product SK12297A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9415330A GB9415330D0 (en) 1994-07-29 1994-07-29 Novel compounds
GBGB9425599.9A GB9425599D0 (en) 1994-12-19 1994-12-19 Novel compounds
GBGB9509923.0A GB9509923D0 (en) 1995-05-17 1995-05-17 Novel compounds
PCT/EP1995/003038 WO1996004260A1 (en) 1994-07-29 1995-07-28 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes

Publications (1)

Publication Number Publication Date
SK12297A3 true SK12297A3 (en) 1997-08-06

Family

ID=27267309

Family Applications (1)

Application Number Title Priority Date Filing Date
SK122-97A SK12297A3 (en) 1994-07-29 1995-07-28 Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product

Country Status (16)

Country Link
EP (1) EP0772605A1 (cs)
AP (1) AP776A (cs)
BR (1) BR9508468A (cs)
CA (1) CA2196079A1 (cs)
CZ (1) CZ25497A3 (cs)
DZ (1) DZ1916A1 (cs)
FI (1) FI970357A (cs)
HU (1) HUT76637A (cs)
IL (3) IL125525A (cs)
MA (1) MA23632A1 (cs)
MX (1) MX9700763A (cs)
NO (1) NO307827B1 (cs)
OA (1) OA10470A (cs)
PL (1) PL318766A1 (cs)
SK (1) SK12297A3 (cs)
WO (2) WO1996004261A1 (cs)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
RU2169141C2 (ru) * 1996-04-04 2001-06-20 Санкио Компани Лимитед Производные фенилалкилкарбоновой кислоты и фармацевтическая композиция на их основе
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
TR200000896T2 (tr) 1997-10-02 2000-09-21 Sankyo Company Limited Amidokarboksilik asit türevleri.
US6265401B1 (en) 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
GB2364304B (en) * 1997-10-27 2003-04-23 Reddy Research Foundation Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
RU2247722C2 (ru) 1997-10-27 2005-03-10 Др. Редди`З Лабораториз Лимитед Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
WO1999016758A1 (en) * 1997-10-27 1999-04-08 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) * 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
JP2002507543A (ja) * 1998-05-27 2002-03-12 ドクター・レディーズ・リサーチ・ファウンデーション 二環系化合物、その製造方法およびそれらを含有する薬学的組成物
CN1317970A (zh) 1998-09-17 2001-10-17 布里斯托尔-迈尔斯斯奎布公司 用aP2抑制剂和组合剂治疗动脉粥样硬化的方法
JP2002527503A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物類、それらの調製及び使用
US6365586B1 (en) 1998-10-21 2002-04-02 Novo Nordisk A/S Compounds, their preparation and use
AU6325799A (en) * 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
US6300339B1 (en) 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
US6214820B1 (en) 1998-10-21 2001-04-10 Novo Nordisk A/S Compounds, their preparation and use
WO2000023416A1 (en) * 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
AU6190199A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
JP2002527516A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、それらの製造及び使用
US6248781B1 (en) 1998-10-21 2001-06-19 Novo Nordisk A/S Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
US6468996B1 (en) 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
JP2002527507A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物類、それらの調製及び使用
NZ510904A (en) * 1998-10-29 2003-08-29 Dr An process for the preparation of antidiabetic agents
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
AU3957800A (en) * 1999-04-16 2000-11-02 Dr. Reddy's Research Foundation Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate
US6972294B1 (en) 1999-04-20 2005-12-06 Novo Nordisk, A/S Compounds, their preparation and use
JP2002542246A (ja) 1999-04-20 2002-12-10 ノボ ノルディスク アクティーゼルスカブ 新規な化合物、それらの製造及び使用
US7414128B2 (en) 1999-04-20 2008-08-19 Dr. Reddy's Laboratories, Limited Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate
IL145789A0 (en) * 1999-04-20 2002-07-25 Novo Nordisk As Derivatives of propionic acid, their preparation and pharmaceutical compositions containing them
AU3957900A (en) * 1999-04-20 2000-11-02 Novo Nordisk A/S New compounds, their preparation and use
US6369055B1 (en) 1999-04-20 2002-04-09 Novo Nordisk A/S Compounds, their preparation and use
US6274608B1 (en) 1999-04-20 2001-08-14 Novo Nordisk A/S Compounds, their preparation and use
IL146104A0 (en) * 1999-04-28 2002-07-25 Reddy Research Foundation Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
AU7073400A (en) 1999-08-27 2001-03-26 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
DZ3279A1 (fr) * 2000-01-19 2001-07-26 Cadila Healthcare Ltd Nouveaux composes ayant des activites hypolipidemiques et hypocholesterolemiques, procede pour leur preparation et compositions pharmaceutiques les contenant
US6555577B1 (en) 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
US6569901B2 (en) 2000-01-28 2003-05-27 Novo Nordisk A/S Alkynyl-substituted propionic acid derivatives, their preparation and use
KR20020090211A (ko) * 2000-01-28 2002-11-30 노보 노르디스크 에이/에스 알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용
US6509374B2 (en) 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use
AU2001263083A1 (en) 2000-05-12 2001-11-26 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4h-benzo(1,4)oxazin-3-ones
WO2001087860A2 (en) * 2000-05-12 2001-11-22 Ortho-Mcneil Pharmaceutical, Inc. Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
WO2001087861A2 (en) * 2000-05-12 2001-11-22 Ortho-Mcneil Pharmaceutical, Inc. Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US6869967B2 (en) 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
US7067530B2 (en) 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
US7220877B2 (en) 2001-10-17 2007-05-22 Novo Nordisk A/S Compounds, their preparation and use
WO2003059378A2 (en) 2001-12-29 2003-07-24 Novo Nordisk A/S Combined use of a glp-1 compound and another drug for treating dyslipidemia
US7015345B2 (en) 2002-02-21 2006-03-21 Asahi Kasei Pharma Corporation Propionic acid derivatives
US7816385B2 (en) 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
EP2154131A4 (en) * 2007-04-26 2011-09-21 Pharmafrontier Co Ltd INHIBITOR OF THE G-PROTEIN-COUPLED RECEPTOR AND PHARMACEUTICAL PRODUCT
CA2825456C (en) 2011-01-31 2016-01-05 Cadila Healthcare Limited Treatment for lipodystrophy
WO2014174524A1 (en) 2013-04-22 2014-10-30 Cadila Healthcare Limited A novel composition for nonalcoholic fatty liver disease (nafld)
MX2015016403A (es) 2013-05-30 2016-04-11 Cadila Healthcare Ltd Proceso para la preparacion de pirroles que tienen actividad hipolipidemica e hipocolesterolemica.
TW201636015A (zh) 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物
IN2013MU02470A (cs) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
WO2015033357A2 (en) 2013-09-06 2015-03-12 Cadila Healthcare Limited An improved process for the preparation of pyrrole derivatives
WO2017064635A2 (en) 2015-10-14 2017-04-20 Cadila Healthcare Limited Pyrrole compound, compositions and process for preparation thereof
US20180243263A1 (en) 2016-12-09 2018-08-30 Cadila Healthcare Ltd. Treatment for primary biliary cholangitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
PL174610B1 (pl) * 1992-07-03 1998-08-31 Smithkline Beecham Plc Nowe związki heterocykliczne

Also Published As

Publication number Publication date
AP776A (en) 1999-10-28
IL125525A0 (en) 1999-03-12
WO1996004260A1 (en) 1996-02-15
OA10470A (en) 2002-04-08
NO970373L (no) 1997-03-18
NO307827B1 (no) 2000-06-05
IL114759A (en) 1999-10-28
IL114759A0 (en) 1995-12-31
HUT76637A (en) 1997-10-28
EP0772605A1 (en) 1997-05-14
NO970373D0 (no) 1997-01-28
AP9700918A0 (en) 1997-01-31
FI970357A (fi) 1997-03-26
CZ25497A3 (en) 1997-09-17
WO1996004261A1 (en) 1996-02-15
MA23632A1 (fr) 1996-04-01
DZ1916A1 (fr) 2002-02-17
IL125525A (en) 2000-02-29
PL318766A1 (en) 1997-07-07
MX9700763A (es) 1997-05-31
FI970357A0 (fi) 1997-01-28
CA2196079A1 (en) 1996-02-15
BR9508468A (pt) 1997-11-25

Similar Documents

Publication Publication Date Title
SK12297A3 (en) Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product
DE69403823T2 (de) Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit
CA3076150C (en) Selective p2x3 modulators
JP4229701B2 (ja) β−ラクタム化合物及びその製造方法並びにこれを含有する血清コレステロール低下剤
DE69220258T2 (de) Azabicyclische Verbindungen, diese enthaltende pharmazeutische Zubereitungen und ihre therapeutische Verwendung
RU2133743C1 (ru) Производные оксазолидин-2-она и лекарственное средство на их основе
DE60107820T2 (de) Neue verwendung von phenylheteroalkylamin-derivaten
KR19990077099A (ko) 증후군 x의 치료를 위한 ppar-알파 및 ppar-감마 길항제의 용도
WO1994013650A1 (en) Heterocyclic derivatives and their use in pharmaceuticals
KR20060010770A (ko) 아제티딘카르복스아미드 유도체와 씨비1 수용체로 매개된질병의 치료에 대한 이들의 용도
CA2310627C (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
WO1998021185A1 (fr) Arylurees ou derives d'arylmethylcarbamyle
JPH03101643A (ja) ハロゲノアルキルフェニルアルコール、ケトンおよびそれらの水和物
DE60103033T2 (de) Neue phenylheteroalkylamin-derivate
JPH064604B2 (ja) モルホリン誘導体，それらの製法及びそれらを含有する医薬組成物
CS159192A3 (en) 2-hydroxy-2-phenylethylamino derivatives, process of their preparation andtheir use
JPH03193747A (ja) ２―ヒドロキシ―３―フエノキシプロピルアミノ化合物、該化合物を含有する肥満症及び類縁症状の治療用薬剤学的組成物、該化合物の製造方法、及び中間体
EP1165528B1 (fr) Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
EP4329877A1 (en) Substituted amide macrocyclic compounds with orexin-2 receptor agonist activity
JPH03169841A (ja) アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法
EP4186891A1 (en) Substituted benzimidazole derivative and use thereof
HRP20010566A2 (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
AU697545B2 (en) Benzoxazoles and pyridine derivatives useful in the treatment of the ty pe II diabetes
JPH0347165A (ja) ピロールカルボン酸誘導体
JP3048643B2 (ja) ５，７−ジヒドロ−３−［２−｛１−ベンジルピペリジン−４−イル｝エチル］−６Ｈ−ピロロ−［４，５−ｆ］−１，２−ベンズイソオキサゾール−６−オンの製造方法及び中間体